The economic recession and rising unemployment-plus changing demographics and baby boomers aging into Medicare-are among the factors expected to influence health spending during 2009-2019. In 2009 the health share of gross domestic product (GDP) is expected to have increased 1.1 percentage points to 17.3 percent-the largest single-year increase since 1960. Average public spending growth rates for hospital, physician and clinical services, and prescription drugs are expected to exceed private spending growth in the first four years of the projections. As a result, public spending is projected to account for more than half of all U.S. health care spending by 2012.
In 2010, US health spending is estimated to have grown at a historic low of 3.9 percent, due in part to the effects of the recently ended recession. In 2014, national health spending growth is expected to reach 8.3 percent when major coverage expansions from the Affordable Care Act of 2010 begin. The expanded Medicaid and private insurance coverage are expected to increase demand for health care significantly, particularly for prescription drugs and physician and clinical services. Robust growth in Medicare enrollment, expanded Medicaid coverage, and premium and cost-sharing subsidies for exchange plans are projected to increase the federal government share of health spending from 27 percent in 2009 to 31 percent by 2020. This article provides perspective on how the nation's health care dollar will be spent over the coming decade as the health sector moves quickly toward its new paradigm of expanded insurance coverage. N ational health spending is expected to grow 5.8 percent per year for the period 2010 through 2020, 1.1 percentage points faster than the expected average annual rise in gross domestic product. As a result, the health share of the gross domestic product is projected to increase from 17.6 percent in 2009 to 19.8 percent by 2020.1 During this period, we expect that the Affordable Care Act of 2010 will reduce the number of uninsured people by nearly thirty million, lead to prescription drugs and physician services accounting for a greater share of health spending than would have been the case otherwise, and contribute to an increase in the government-sponsored (federal, state, and local) share of health spending to just under 50 percent by 2020.In this article we review some highlights of overall projected spending trends in several time periods; summarize our methods and assumptions; then provide an outlook for major health industry sectors, payers, and sponsors. In so doing, we provide perspective on how the nation's health care dollar will be spent over the coming decade as the health sector moves quickly toward its new paradigm of expanded insurance coverage. 2010National health spending is estimated to have reached $2.6 trillion in 2010, reflecting a growth rate of 3.9 percent over the previous year, which is slightly slower than the previous historic low growth rate of 4.0 percent in 2009 (Exhibits 1 and 2).2 Growth in nominal gross domestic product (that is, not adjusted for inflation) accelerated to 3.8 percent in 2010 from −1.7 percent in 2009.3 Because the rate of economic growth has accelerated and the projected rate of growth of health spending is similar, the health share of gross domestic product is projected to remain unchanged in 2010 at 17.6 percent. This is in
Growth in national health spending is projected to slow in 2005 to 7.4 percent, from a peak of 9.1 percent in 2002. Private health insurance premiums are projected to slow to 6.6 percent in 2005, with a rebound expected in 2007. The introduction of Medicare Part D drug coverage in 2006 produces a dramatic shift in spending across payers but has little net effect on aggregate spending growth. Health spending is expected to consistently outpace gross domestic product (GDP) over the coming decade, accounting for 20 percent of GDP by 2015.
ABSTRACT:The outlook for national health spending calls for continued steady growth.Spending growth is projected to be 6.7 percent in 2007, similar to its rate in 2006. Average annual growth over the projection period is expected to be 6.7 percent. Slower growth in private spending toward the end of the period is expected to be offset by stronger growth in public spending. The health share of gross domestic product (GDP) is expected to increase to 16. N at i o na l h e a lt h s p e n di n g is expected to grow 6.7 percent in 2007 and reach $2.2 trillion. Over the projection period in this paper (2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017), growth is anticipated to remain steady at around 6.7 percent per year, yielding an estimated $4.3 trillion in health spending in 2017 (Exhibits 1 and 2). Average annual growth for 2005-2016 is 0.2 percentage point lower than projected previously, mostly due to the expectation of slower medical price growth. 1 Gross domestic product (GDP) growth is expected to average 4.7 percent per year over the projection period. Therefore, health spending growth is expected to outpace economic growth by an average of 1.9 percentage points annually. Although this difference in growth rates is larger than was observed in 2004, 2005, and 2006 (averaging 0.3 percentage point), it is lower than the average difference of 2.7 percentage points over the past thirty years.2 The differential growth rates are expected to result in a health share of GDP of 16.3 percent in 2007 and 19.5 percent by 2017-nearly one-fifth of the economy (Exhibit 3).Divergent spending trends in public and private payers' spending, as well as in spending for specific services and goods, underlie the stable outlook for overall growth in national health spending. Although we expect acceleration through 2009 attributable to higher use, private spending growth is expected to decel-T r e n d s erate through the end of the projection period from 6.6 percent in 2009 to 5.9 percent by 2017. Growth in public spending, on the other hand, is expected to accelerate toward the end of the projection period as the leading edge of the baby-boom generation becomes eligible for w 1 4 6 2 6 F e b r u a r y 2 0 0 8 H e a l t h T r a c k i n g Medicare. From the sectoral perspective, prescription drug spending growth is projected to decelerate in 2007, driven by slower price growth, but is expected to accelerate through 2017 as utilization increases. On the other hand, hospital spending is expected to accelerate in 2007 because of higher Medicaid payment rates and then to decelerate toward the end of the projection period in a lagged response to projected lower growth in income.Medicare Part D is expected to have little impact on overall health spending growth dur- ing the projection period. Per capita prescription drug spending growth is assumed to be identical for Medicare beneficiaries and for the population as a whole. 3 However, Medicare Part D enrollment growth is expected to increase at a faster rate than populati...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.